LH stock news · Labcorp Holdings Inc.
Get alerts for LH
Follow Labcorp Holdings Inc. (LH) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for LHFree on the App Store and Google Play, or on the web.
OPKO Health is selling its testing businesses to Labcorp in a big deal worth up to $872 million.
Good for LHLabcorp agreed to buy BioReference testing operations, expected to bring about $250 million in first-year sales. The deal looks favorable, though approval and closing are still pending.
Labcorp Holdings Inc. says it will share its third-quarter financial results on October 28, 2026, before the market opens.
NeutralLabcorp set a date to report its third-quarter results, but shared no results or company forecast. This notice alone does not change its business outlook.
LABCORP HOLDINGS INC. announces changes in its leadership team, including the exit and election of directors, along with the appointment and compensation arrangements for certain officers (LH).
NeutralLabcorp's recent filing indicates significant changes in its leadership team, which could lead to shifts in company strategy and performance. Investors should monitor how these changes may influence Labcorp's operations and market position moving forward.